Position in GRAL
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$2,026,269
+$1,171,397 QoQ
Shares Held
39,208
+292.6% QoQ
Ownership
0.091%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026HighTower Advisors, LLC holds $298,328,835 across 21 Diagnostics & Research names. GRAL ranks #13 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
393,672 | $74,640,211 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
145,001 | $71,272,341 | |
| 3 | MTD |
Mettler Toledo International Inc/
|
33,951 | $42,819,001 | |
| 4 | NTRA |
Natera, Inc.
|
108,536 | $21,706,114 | |
| 5 | LH |
Labcorp Holdings Inc.
|
78,110 | $20,840,529 | |
| 6 | A |
Agilent Technologies, Inc.
|
171,118 | $19,504,029 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
28,526 | $16,028,474 | |
| 8 | DGX |
Quest Diagnostics Inc
|
60,014 | $11,761,543 |
All Filings in GRAL
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,026,269 | 39,208 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $854,872 | 9,988 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $966,479 | 16,345 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $763,329 | 14,845 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $296,034 | 11,591 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $195,707 | 10,964 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||